Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.

Research output: Contribution to journalArticle

Abstract

Predicting any future metastatic site of early-stage breast cancer is important as it significantly influences the prognosis of advanced disease. This study aimed at investigating the potential of claudin-2, over-expressed in breast cancer liver metastases, as a biomarker for predicting liver metastatic propensity in primary breast cancer.

Details

Authors
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cancer and Oncology
Original languageEnglish
Pages (from-to)119-128
JournalMolecular Oncology
Volume8
Issue number1
Publication statusPublished - 2014
Publication categoryResearch
Peer-reviewedYes

Total downloads

No data available

Related research output

Siker Kimbung, 2014, Oncology, MV. 152 p.

Research output: ThesisDoctoral Thesis (compilation)

View all (1)